• OPEN AN ACCOUNT
Indian Indices
Sensex
76,944.28 -12.99
( -0.02%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,431.13 119.20
(0.18%)
Nikkei 225
10,824.26 31.76
(0.29%)
Forex
USD-INR
95.47 -0.01
(-0.01%)
EUR-INR
110.57 -0.67
(-0.60%)
GBP-INR
129.19 -0.55
(-0.42%)
JPY-INR
0.60 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Goldline Pharmaceutical Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
544759
INE1CLW01015
25.0547917
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
38.4
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

ansal properties & infrastructure ltd
Bajaj Auto gains after total sales jump 28% YoY in August’26
Sep 01,2026
Domestic sales rose 10% YoY to 2,55,708 units, while exports grew 51% YoY to 2,80,056 units.

Two-wheeler sales increased 30% YoY to 4,43,748 units, while commercial vehicle sales rose 22% YoY to 92,016 units in August 2026.

Bajaj Auto is engaged in the business of development, manufacturing, and distribution of automobiles such as motorcycles, commercial vehicles, electric two-wheelers, etc., and parts thereof.

The company's standalone profit after tax increased 42.3% YoY to Rs 2,983 crore in Q1 FY27. PAT rose 8.6% QoQ from Rs 2,746 crore in Q4 FY26. Revenue from operations climbed 37.0% YoY and 7.7% QoQ to a record Rs 17,244 crore in Q1 FY27.